Janux Therapeutics EPS Diluted (Quarterly) Analysis

Janux Therapeutics Inc (JANX)

50.47 +3.97 (+8.54%) USD | NASDAQ | Nov 22, 16:00

50.47 0.00 (0.00%) After-Hours: 18:00

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2020. Upgrade now.

Date	Value
September 30, 2024	-0.51
June 30, 2024	-0.11
March 31, 2024	-0.30
December 31, 2023	-0.24
September 30, 2023	-0.25
June 30, 2023	-0.42
March 31, 2023	-0.42
December 31, 2022	-0.39
September 30, 2022	-0.40
June 30, 2022	-0.41

Date	Value
March 31, 2022	-0.32
December 31, 2021	-0.33
September 30, 2021	-0.26
June 30, 2021	-0.62
March 31, 2021	-0.0572
December 31, 2020	-0.1327
September 30, 2020	-0.1007
June 30, 2020	-0.1972
March 31, 2020	-0.1133

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Quarterly) Range, Past 5 Years

-0.62

Minimum

Jun 2021

-0.0572

Maximum

Mar 2021

-0.2937

Average

-0.30

Median

Mar 2024

EPS Diluted (Quarterly) Benchmarks

Dynavax Technologies Corp	0.12
Krystal Biotech Inc	0.91
NovaBay Pharmaceuticals Inc	-0.60
Palatin Technologies Inc	-0.39
iBio Inc	-0.46

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly)	-28.06M
Revenue (Quarterly)	0.439M
Total Expenses (Quarterly)	36.28M
Enterprise Value	1.782B
Profit Margin (Quarterly)	-6.39K%
Earnings Yield	-2.30%
Normalized Earnings Yield	-2.298